함께 비교하는 진짜 ADC · Antibody · CGT 데이터

CGTBiologicstaleSt. Jude Children's Research Ho…Phase 2

SJCAR19 product (CD19- specific CAR engineered autologous T-cells, CD19- specific CAR engineered autologous T-cells (SJCAR19 product))

Acute Lymphoblastic Leukemia, in Relapse; Acute Lymphoblastic Leukemia, Refractory · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4

효능 ORR 20%임상시험 1상태 RECRUITING

#ArthritisJuvenileIdiopathic#Antibody#Phase3#항체#면역항체+4

adalimumab (Humira, OLE BSA Adalimumab +/- MTX)

Arthritis, Juvenile Idiopathic · Arthritis, Juvenile Idiopathic

adalimumab-US (Humira, Humira (adalimumab-US))

Healthy · Healthy

AntibodystaleAbbViePreclinical

adalimumab (Humira, Application of Adalimumab)

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Preclinical#항체#면역항체+2

adalimumab-EU (Humira, Humira (adalimumab-EU))

Healthy · Healthy

AntibodystaleEvangelos J. Giamarellos-Bourbo…Phase 2

MABp1 (MABp1)

Hidradenitis Suppurativa · Hidradenitis Suppurativa

#HidradenitisSuppurativa#Antibody#Phase2#항체#면역항체+2

AntibodystaleBiocadPhase 3

Netakimab (Netakimab)

Plaque Psoriasis · Plaque Psoriasis

#PlaquePsoriasis#Antibody#Phase3#항체#면역항체+2

AntibodystaleAbbViePhase 2

adalimumab (Humira, FITC-Adalimumab)

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Phase2#항체#면역항체+2

CGTBiologicstaleTcelltech Inc.Phase 1

In Vivo CAR-T Therapy (In Vivo CAR-T Therapy)

Relapsed or Refractory Hematologic Malignancies · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+3

#Pharmacokinetics#Antibody#Phase3#항체#면역항체+3

Adalimumab (Advixa, Advixa (Adalimumab))

Pharmacokinetics; Safety · Pharmacokinetics

CGTBiologicstaleMedical College of WisconsinPhase 1

Auto CD34+PBSC, transduced with a lentiviral vector encoding the B domain deleted from of human coagulation factor VIII (Auto CD34+PBSC, transduced with a lentiviral vector encoding the B domain deleted from of human coagulation factor VIII)

Hemophilia A · CD3

#CD3#CGT#Phase1#세포유전치료#CAR-T+3

CGTBiologicstaleBeijing Boren HospitalPhase 1

0.5 x 10^6 CAR-T+ cells/kg，1.0 x 10^6 CAR-T+ cells/kg (CI-135 CAR-T cells, CI-135 CAR-T cells (0.5 x 10^6 CAR-T+ cells/kg，1.0 x 10^6 CAR-T+ cells/kg))

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase1#세포유전치료#CAR-T+2

CGTAAVBiologicstaleMedical Research CouncilPhase 2

AAV2/8-HLP-FVIII-V3 (AAV2/8-HLP-FVIII-V3)

Hemophilia A · Hemophilia A

#HemophiliaA#CGT#Phase2#세포유전치료#CAR-T+2

CGTBiologicstaleOhio State University Comprehen…Phase 1

Anti-GARP Chimeric Antigen Receptor-T Cells (Anti-GARP Chimeric Antigen Receptor-T Cells)

Recurrent Malignant Glioma; Recurrent WHO Grade 3 Glioma · Recurrent Malignant Glioma

#RecurrentMalignantGlioma#CGT#Phase1#세포유전치료#CAR-T+3

CGTBiologicstaleSt. Jude Children's Research Ho…Phase 1

Autologous (CD70-CAR T cell infusion, CD70-CAR T cell infusion (Autologous))

Hematologic Malignancy; ALL, Childhood · Hematologic Malignancy

#HematologicMalignancy#CGT#Phase1#세포유전치료#CAR-T+4

CGTBiologicstaleAvenCell Europe GmbHPhase 1

UniCAR02-T-pPSMA (UniCAR02-T-pPSMA)

Prostate Cancer · PSMA

#PSMA#CGT#Phase1#세포유전치료#CAR-T+3

CGTAAVBiologicstaleUnlimited Biotechnology LLCPhase 2

AAV9-Follistatin gene therapy (AAV9-Follistatin gene therapy)

Age-related Muscle Decline · Age-related Muscle Decline

CGTBiologicstaleShanghai First Song Biotechnolo…Phase 1

anti-CD19-CAR T-cells, or anti-CD30-CAR T-cells, or anti-CD20/CD30-CAR T-cells (anti-CD19-CAR T-cells, or anti-CD30-CAR T-cells, or anti-CD20/CD30-CAR T-cells)

Relapsed/refractory Lymphoma; Relapsed/Refractory Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4

CGTBiologicstaleThird Military Medical Universi…Phase 1

CD19 CAR and PD-1 knock out engineered T-cells (CD19 CAR and PD-1 knock out engineered T-cells)

Acute Lymphoblastic Leukemia; Burkitt Lymphoma · PD-1

#PD-1#CGT#Phase1#세포유전치료#CAR-T+4

CGTAAVBiologicstaleTippi MackenziePhase 1

Gene Transfer with an AAV9 Vector Expressing Human ß-galactosidase (Gene Transfer with an AAV9 Vector Expressing Human ß-galactosidase)

GM1 Gangliosidoses; GM1 Gangliosidosis, Type I · GM1 Gangliosidoses

#GM1Gangliosidoses#CGT#Phase1#세포유전치료#CAR-T+4

ADCBiologicstaleAstellas Pharma Global Developm…Phase 1

AGS15E (AGS15E)

Metastatic Urothelial Cancer · Metastatic Urothelial Cancer

#MetastaticUrothelialCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

CGTBiologicstaleGuangzhou Anjie Biomedical Tech…Phase 2

AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells (AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells)

Advanced Breast Cancer; Breast Neoplasm Malignant Female · PD-1

#PD-1#CGT#Phase2#세포유전치료#CAR-T+4

CGTBiologicstaleCandel Therapeutics, Inc.Phase 2

ADV-TK (ADV-TK, adenovirus-thymidine kinase enzyme, ADV-TK (adenovirus-thymidine kinase enzyme) gene therapy)

Hepatocellular Carcinoma; Liver Transplantation · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Phase2#세포유전치료#CAR-T+3

효능 ORR 11%임상시험 1상태 ACTIVE

CGTBiologicstaleGuangzhou Bio-gene Technology C…Phase 2

CD19 CAR-T cell infusion (CD19 CAR-T cell infusion)

Systemic Lupus Erythematosus · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+3

7880갱신 대기 S–CData Tier S/A/B차세대 →Insight 1032HER2 breast 4684Antibody 2713CGT →Psoriasis →NSCLC 44FDA 승인

137 / 142 페이지

← 이전 다음 →

전체 8,429개 프로그램 보기

갱신 기록 없음 · 14일 주기 · 방문 109 / 21,834

8429프로그램 44FDA 승인

109오늘 방문

21,834누적 방문

피드 Data Tier 차세대 Insight

Sonelokimab (Sonelokimab)

Arthritis, Psoriatic · Arthritis, Psoriatic

#ArthritisPsoriatic#Antibody#Phase2#항체#면역항체+4

CGTBiologicstaleSt. Jude Children's Research Ho…Phase 2

SJCAR19 product (CD19- specific CAR engineered autologous T-cells, CD19- specific CAR engineered autologous T-cells (SJCAR19 product))

Acute Lymphoblastic Leukemia, in Relapse; Acute Lymphoblastic Leukemia, Refractory · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4

효능 ORR 20%임상시험 1상태 RECRUITING

#ArthritisJuvenileIdiopathic#Antibody#Phase3#항체#면역항체+4

adalimumab (Humira, OLE BSA Adalimumab +/- MTX)

Arthritis, Juvenile Idiopathic · Arthritis, Juvenile Idiopathic

adalimumab-US (Humira, Humira (adalimumab-US))

Healthy · Healthy

AntibodystaleAbbViePreclinical

adalimumab (Humira, Application of Adalimumab)

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Preclinical#항체#면역항체+2

adalimumab-EU (Humira, Humira (adalimumab-EU))

Healthy · Healthy

AntibodystaleEvangelos J. Giamarellos-Bourbo…Phase 2

MABp1 (MABp1)

Hidradenitis Suppurativa · Hidradenitis Suppurativa

#HidradenitisSuppurativa#Antibody#Phase2#항체#면역항체+2

AntibodystaleBiocadPhase 3

Netakimab (Netakimab)

Plaque Psoriasis · Plaque Psoriasis

#PlaquePsoriasis#Antibody#Phase3#항체#면역항체+2

AntibodystaleAbbViePhase 2

adalimumab (Humira, FITC-Adalimumab)

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Phase2#항체#면역항체+2

CGTBiologicstaleTcelltech Inc.Phase 1

In Vivo CAR-T Therapy (In Vivo CAR-T Therapy)

Relapsed or Refractory Hematologic Malignancies · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+3

#Pharmacokinetics#Antibody#Phase3#항체#면역항체+3

Adalimumab (Advixa, Advixa (Adalimumab))

Pharmacokinetics; Safety · Pharmacokinetics

CGTBiologicstaleMedical College of WisconsinPhase 1

Auto CD34+PBSC, transduced with a lentiviral vector encoding the B domain deleted from of human coagulation factor VIII (Auto CD34+PBSC, transduced with a lentiviral vector encoding the B domain deleted from of human coagulation factor VIII)

Hemophilia A · CD3

#CD3#CGT#Phase1#세포유전치료#CAR-T+3

CGTBiologicstaleBeijing Boren HospitalPhase 1

0.5 x 10^6 CAR-T+ cells/kg，1.0 x 10^6 CAR-T+ cells/kg (CI-135 CAR-T cells, CI-135 CAR-T cells (0.5 x 10^6 CAR-T+ cells/kg，1.0 x 10^6 CAR-T+ cells/kg))

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase1#세포유전치료#CAR-T+2

CGTAAVBiologicstaleMedical Research CouncilPhase 2

AAV2/8-HLP-FVIII-V3 (AAV2/8-HLP-FVIII-V3)

Hemophilia A · Hemophilia A

#HemophiliaA#CGT#Phase2#세포유전치료#CAR-T+2

CGTBiologicstaleOhio State University Comprehen…Phase 1

Anti-GARP Chimeric Antigen Receptor-T Cells (Anti-GARP Chimeric Antigen Receptor-T Cells)

Recurrent Malignant Glioma; Recurrent WHO Grade 3 Glioma · Recurrent Malignant Glioma

#RecurrentMalignantGlioma#CGT#Phase1#세포유전치료#CAR-T+3

CGTBiologicstaleSt. Jude Children's Research Ho…Phase 1

Autologous (CD70-CAR T cell infusion, CD70-CAR T cell infusion (Autologous))

Hematologic Malignancy; ALL, Childhood · Hematologic Malignancy

#HematologicMalignancy#CGT#Phase1#세포유전치료#CAR-T+4

CGTBiologicstaleAvenCell Europe GmbHPhase 1

UniCAR02-T-pPSMA (UniCAR02-T-pPSMA)

Prostate Cancer · PSMA

#PSMA#CGT#Phase1#세포유전치료#CAR-T+3

CGTAAVBiologicstaleUnlimited Biotechnology LLCPhase 2

AAV9-Follistatin gene therapy (AAV9-Follistatin gene therapy)

Age-related Muscle Decline · Age-related Muscle Decline

CGTBiologicstaleShanghai First Song Biotechnolo…Phase 1

anti-CD19-CAR T-cells, or anti-CD30-CAR T-cells, or anti-CD20/CD30-CAR T-cells (anti-CD19-CAR T-cells, or anti-CD30-CAR T-cells, or anti-CD20/CD30-CAR T-cells)

Relapsed/refractory Lymphoma; Relapsed/Refractory Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4

CGTBiologicstaleThird Military Medical Universi…Phase 1

CD19 CAR and PD-1 knock out engineered T-cells (CD19 CAR and PD-1 knock out engineered T-cells)

Acute Lymphoblastic Leukemia; Burkitt Lymphoma · PD-1

#PD-1#CGT#Phase1#세포유전치료#CAR-T+4

CGTAAVBiologicstaleTippi MackenziePhase 1

Gene Transfer with an AAV9 Vector Expressing Human ß-galactosidase (Gene Transfer with an AAV9 Vector Expressing Human ß-galactosidase)

GM1 Gangliosidoses; GM1 Gangliosidosis, Type I · GM1 Gangliosidoses

#GM1Gangliosidoses#CGT#Phase1#세포유전치료#CAR-T+4

ADCBiologicstaleAstellas Pharma Global Developm…Phase 1

AGS15E (AGS15E)

Metastatic Urothelial Cancer · Metastatic Urothelial Cancer

#MetastaticUrothelialCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

CGTBiologicstaleGuangzhou Anjie Biomedical Tech…Phase 2

AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells (AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells)

Advanced Breast Cancer; Breast Neoplasm Malignant Female · PD-1

#PD-1#CGT#Phase2#세포유전치료#CAR-T+4

CGTBiologicstaleCandel Therapeutics, Inc.Phase 2

ADV-TK (ADV-TK, adenovirus-thymidine kinase enzyme, ADV-TK (adenovirus-thymidine kinase enzyme) gene therapy)

Hepatocellular Carcinoma; Liver Transplantation · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Phase2#세포유전치료#CAR-T+3

효능 ORR 11%임상시험 1상태 ACTIVE

CGTBiologicstaleGuangzhou Bio-gene Technology C…Phase 2

CD19 CAR-T cell infusion (CD19 CAR-T cell infusion)

Systemic Lupus Erythematosus · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+3